Immunomedics regulatory update

IMMU received a U.S. patent and a notice of allowance for a U.S. patent, both covering its imaging technologies. U.S. Patent No. 5,525,338 covers a multi-step, pre-targeting method that increases both the binding of antibodies to cancers or other disease tissues, as well as the deposition of the detection or therapeutic agents in lesions. ...